钴试剂
恩曲他滨
替诺福韦-阿拉芬酰胺
埃替拉韦
医学
人类免疫缺陷病毒(HIV)
埃法维伦兹
病毒学
抗逆转录病毒疗法
病毒载量
作者
Fujie Zhang,Hao Wu,Weiping Cai,Ping Ma,Qingxia Zhao,Hongxia Wei,Hongzhou Lu,Hui Wang,Shenghua He,Chen Zhu,Yaokai Chen,Li Wang,Wan Norhaniza Wan Hasan,Hu Fu,Hong Qin
标识
DOI:10.1016/j.lanwpc.2024.101143
摘要
We compared the efficacy and safety profiles of ainuovirine (ANV), a new-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), with boosted elvitegravir (EVG), both coformulated with two nucleoside reverse transcriptase inhibitors (NRTIs), in people living with HIV-1 (PLWH) who had achieved virological suppression on previous NNRTI-based antiretroviral (ARV) regimen.
科研通智能强力驱动
Strongly Powered by AbleSci AI